National Cancer Institute

FY 2010 Research Funding by Research Topic

Cancer Type Funded Amount
Agent Orange/Dioxin Related $1,770,892
Aging $123,095,361
Alcoholism Research $684,408
Arctic $684,462
Arthritis $740,616
Ataxia Telangiectasia $3,658,153
Autoimmune Diseases $12,599,993
Basic Behavioral and Social Science $81,557,481
Behavioral and Social Science $321,385,107
Biochemical Epidemiology $260,370,797
Bioengineering $168,183,394
Bone Marrow Transplantation $64,195,092
Cancer $5,098,146,876
Cancer Survivorship $243,469,211
Cervical Cancer Education $6,694,169
Chemoprevention $135,897,018
Chemotherapy $522,770,634
Childhood Cancers $197,126,947
Chronic Myeloproliferative Disorders $33,983,890
Contraception and Reproduction Research $2,559,589
Depression Research $10,286,909
Diabetes $5,004,221
Digestive Diseases $465,474,914
Down Syndrome $887,290
Gene Therapy $72,081,945
Gene Therapy Clinical Trials $9,851,875
Genetic Testing $120,222,265
Herpes - Genital $582,723
Herpes - Other $49,976,935
Inflammatory Bowel Disease $3,528,381
Interferon $10,324,539
Metastasis $385,223,790
Neurofibromatosis $9,802,754
Nuclear Magnetic Resonance Imaging (NMR) $75,082,982
Nursing Oncology $19,704,726
Organ Transplantation Research $77,288,304
Pesticides $3,035,579
Sleep Disorders $9,323,183
Smoking Behavior $84,560,516
Surgery $81,621,520
Taxol $74,362,100
Tuberous Sclerosis $4,957,102